A recent study showed that NLRP3 inflammasome activation is needed for the development of hepatic steatosis, where Nlrp3−/− mice were protected against hepatomegaly, liver injuries, and infiltration of activated macrophages in a long-term manner (33). Here, NLRP3 is linked to fatty liver disease.